Tiam1 mutations in human renal-cell carcinomas.

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Tiam1-Rac1 signaling influences cell invasion, but its role in human tumors is largely unexplored.
• Previous research indicates varied effects of Tiam1-Rac1 signaling on invasion across different cell types.

Purpose of the Study:

• To investigate the role of Tiam1 and Rac1 in human renal cell carcinoma (RCC) invasion.
• To identify and characterize mutations in Tiam1 and Rac1 in RCC.

Main Methods:

• Analyzed Tiam1 and Rac1 expression levels in RCC cell lines and correlated them with in vitro invasiveness.
• Performed mutation analysis on Tiam1 and Rac1 genes in RCC cell lines and primary tumors.
• Assessed the functional impact of a specific Tiam1 mutation (A441G) through cell transformation assays in NIH3T3 cells.

Main Results:

• Tiam1 expression inversely correlated with invasiveness in most RCC cell lines; Rac1 expression showed no clear correlation.
• Identified several Tiam1 point mutations, including A441G in the pleckstrin homology domain, in RCC cell lines and primary tumors.
• The A441G Tiam1 mutation was found in 11.5% of RCCs and induced NIH3T3 cell transformation, indicating dominant active function.

Conclusions:

• A novel Tiam1 mutation (A441G) is present in human RCCs and may contribute to tumor progression.
• The identified Tiam1 mutation exhibits oncogenic properties, driving cell transformation.
• Further research into Tiam1 mutations in human cancers could reveal new insights into tumor development.